Administration of Intravenous Ferric Carboxymaltose in a Patient With Iron-Deficiency Anemia and Allergy to 2 Oral Iron Preparations.

Q2 Medicine
Jordan Wallace, Adriana Trabal
{"title":"Administration of Intravenous Ferric Carboxymaltose in a Patient With Iron-Deficiency Anemia and Allergy to 2 Oral Iron Preparations.","authors":"Jordan Wallace, Adriana Trabal","doi":"10.5863/JPPT-26-00105","DOIUrl":null,"url":null,"abstract":"<p><p>Iron deficiency is a common occurrence in the pediatric population, often leading to the development of anemia. The first line of treatment is oral iron administration for the resolution of anemia and replenishment of iron stores. Although rare, patients may present with allergic reactions to iron, which can limit treatment modalities. We present the case of a 14-month-old boy who presented with iron-deficiency anemia and demonstrated allergy to 2 oral iron formulations. Our institution developed a treatment plan that includes adding premedications and slowly titrating of the infusion rate for the administration of intravenous iron. The patient successfully tolerated 2 infusions without developing allergic reactions and experienced resolution of his iron-deficiency anemia. When patients with iron-deficiency anemia are allergic to oral iron formulations, their treatment options are limited. There are a few reports of effective desensitizations with intravenous ferric carboxymaltose in pediatric patients. Our successful experience may help guide other institutions with similar patients.</p>","PeriodicalId":37484,"journal":{"name":"Journal of Pediatric Pharmacology and Therapeutics","volume":"31 2","pages":"266-269"},"PeriodicalIF":0.0000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13075392/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Pharmacology and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5863/JPPT-26-00105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Iron deficiency is a common occurrence in the pediatric population, often leading to the development of anemia. The first line of treatment is oral iron administration for the resolution of anemia and replenishment of iron stores. Although rare, patients may present with allergic reactions to iron, which can limit treatment modalities. We present the case of a 14-month-old boy who presented with iron-deficiency anemia and demonstrated allergy to 2 oral iron formulations. Our institution developed a treatment plan that includes adding premedications and slowly titrating of the infusion rate for the administration of intravenous iron. The patient successfully tolerated 2 infusions without developing allergic reactions and experienced resolution of his iron-deficiency anemia. When patients with iron-deficiency anemia are allergic to oral iron formulations, their treatment options are limited. There are a few reports of effective desensitizations with intravenous ferric carboxymaltose in pediatric patients. Our successful experience may help guide other institutions with similar patients.

静脉注射羧麦芽糖铁治疗缺铁性贫血并对2种口服铁制剂过敏的患者。
缺铁在儿科人群中很常见,经常导致贫血的发展。治疗的第一线是口服铁,以解决贫血和补充铁储备。虽然罕见,但患者可能出现对铁的过敏反应,这可能限制治疗方式。我们提出的情况下,一个14个月大的男孩谁提出缺铁性贫血,并证明过敏2口服铁制剂。我们的机构制定了一项治疗计划,其中包括添加预用药和缓慢滴定静脉注射铁的输注速率。患者成功耐受2次输注,未发生过敏反应,缺铁性贫血得到缓解。当缺铁性贫血患者对口服铁制剂过敏时,他们的治疗选择有限。有一些报告有效脱敏与静脉注射铁羧麦芽糖在儿科患者。我们的成功经验可以为其他有类似患者的机构提供指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pediatric Pharmacology and Therapeutics
Journal of Pediatric Pharmacology and Therapeutics Medicine-Pediatrics, Perinatology and Child Health
CiteScore
2.40
自引率
0.00%
发文量
90
期刊介绍: The Journal of Pediatric Pharmacology and Therapeutics is the official journal of the Pediatric Pharmacy Advocacy Group. JPPT is a peer-reviewed multi disciplinary journal that is devoted to promoting the safe and effective use of medications in infants and children. To this end, the journal publishes practical information for all practitioners who provide care to pediatric patients. Each issue includes review articles, original clinical investigations, case reports, editorials, and other information relevant to pediatric medication therapy. The Journal focuses all work on issues related to the practice of pediatric pharmacology and therapeutics. The scope of content includes pharmacotherapy, extemporaneous compounding, dosing, methods of medication administration, medication error prevention, and legislative issues. The Journal will contain original research, review articles, short subjects, case reports, clinical investigations, editorials, and news from such organizations as the Pediatric Pharmacy Advocacy Group, the FDA, the American Academy of Pediatrics, the American Society of Health-System Pharmacists, and so on.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书